Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease
Beach, T. G.; Russell, A.; Sue, L. I.; Intorcia, A. J.; Glass, M. J.; Walker, J. E.; Arce, R.; Nelson, C. M.; Hidalgo, T.; Chiarolanza, G.; Mariner, M.; Scroggins, A.; Pullen, J.; Souders, L.; Sivananthan, K.; Carter, N.; Saxon-LaBelle, M.; Hoffman, B.; Garcia, A.; Callan, M.; Fornwalt, B. E.; Carew, J.; Filon, J.; Cutler, B.; Papa, J.; Curry, J. R.; Oliver, J.; Shprecher, D.; Atri, A.; Belden, C.; Shill, H. A.; Driver-Dunckley, E.; Mehta, S.; Adler, C. H.; Haarer, C. F.; Ruhlen, T.; Torres, M.; Nguyen, S.; Schmitt, D.; Fietz, M.; Lue, L.-F.; Walker, D. G.; Mizgerd, J. P.; Serrano, G. E.
Show abstract
There has been a markedly renewed interest in factors associated with pneumonia, a leading cause of death worldwide, due to its frequent concurrence with pandemics of influenza and Covid-19 disease. Reported predisposing factors to both bacterial pneumonia and pandemic viral lower respiratory infections are wintertime occurrence, older age, obesity, pre-existing cardiopulmonary conditions and diabetes. Also implicated are age-related neurodegenerative diseases that cause parkinsonism and dementia. We investigated the prevalence of autopsy-proven pneumonia in the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND), a longitudinal clinicopathological study, between the years 2006 and 2019 and before the beginning of the Covid-19 pandemic. Of 691 subjects dying at advanced ages (mean 83.4), pneumonia was diagnosed postmortem in 343 (49.6%). There were 185 subjects without dementia or parkinsonism while clinicopathological diagnoses for the other subjects included 319 with Alzheimers disease dementia, 127 with idiopathic Parkinsons disease, 72 with dementia with Lewy bodies, 49 with progressive supranuclear palsy and 78 with vascular dementia. Subjects with one or more of these neurodegenerative diseases all had higher pneumonia rates, ranging between 50 and 61%, as compared to those without dementia or parkinsonism (40%). In multivariable logistic regression models, male sex and a non-summer death both had independent contributions (ORs of 1.67 and 1.53) towards the presence of pneumonia at autopsy while the absence of parkinsonism or dementia was a significant negative predictor of pneumonia (OR 0.54). Male sex, dementia and parkinsonism may also be risk factors for Covid-19 pneumonia. The apolipoprotein E4 allele, as well as obesity, chronic obstructive pulmonary disease, diabetes, hypertension, congestive heart failure, cardiomegaly and cigarette smoking history, were not significantly associated with pneumonia, in contradistinction to what has been reported for Covid-19 disease.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark 88%
- Serum neopterin levels in relation to mild and severe COVID-19 87%
- Divergences on expected pneumonia cases during the COVID-19 epidemic in Catalonia: A time-series analysis of primary care electronic health records covering about 6 million people 87%
Similar papers in this journal
- Alzheimer Disease Neuropathological Comorbidities Are Common in the Younger-Old 94%
- Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 93%
- The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa 93%
Similar papers in this journal
- Poor odor identification predicts mortality risk in older adults without neurodegenerative diseases: the Shanghai Aging Study 92%
- Clinical Suspicion of COVID-19 in Nursing Home residents: symptoms and mortality risk factors 89%
- Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study 88%
Similar papers in this journal
- The Australian Parkinson’s Genetics Study (APGS) - pilot (N = 1,532) 93%
- Optimising activity and diet compositions for dementia prevention: Protocol for the ACTIVate prospective longitudinal cohort study 90%
- The New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.